Gilead won U.S. approval for HIV prevention shot, but when will low-income countries gain sufficient access? The company faces a daunting mix of uncertainty and criticism over its steps to widen availability

https://www.statnews.com/pharmalot/2025/06/18/gilead-hiv-prevention-shot-poor-countries-access-aids-infectious-disease-medicine-pharma-biotech/